Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: APYX

Apyx Medical Corporation

Healthcare | Medical - Devices

No licensed closing price on file for APYX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.20

Apyx Medical Corporation (NASDAQ: APYX) is a medical device company. Figures from SEC EDGAR; updated 2026-10-21 07:28 UTC.

What Apyx Medical Corporation does

Apyx Medical is a surgical aesthetics company incorporated in Delaware that develops and markets medical devices for cosmetic and hospital surgical procedures. The company's primary products include Renuvion and J-Plasma, which use Helium Plasma Platform Technology to deliver controlled heat to tissue, and AYON, an FDA-cleared body contouring system that combines fat removal, tissue contouring, and electrosurgical capabilities. In 2025, the company received FDA clearance for AYON and commenced its commercial launch, while also expanding Renuvion into the China market.

Summarized from Apyx Medical Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.20
Debt/equity3.52

Revenue, margins & earnings

FY2021: net loss $15M on revenue $49M$49MFY2021FY2022: net loss $23M on revenue $45M$45MFY2022FY2023: net loss $19M on revenue $52M$52MFY2023FY2024: net loss $23M on revenue $48M$48MFY2024FY2025: net loss $11M on revenue $53M$53MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-07-02
Most recent filed transactions — July 2026:
  • 2026-07-02DirectorTax withholding-5,024$22.6K
  • 2026-07-02DirectorOption exercise12,000$22.6K
  • 2026-07-02DirectorStock option (right to buy)Option exercise-12,000—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Apyx Medical Corporation do?

Apyx Medical is a surgical aesthetics company incorporated in Delaware that develops and markets medical devices for cosmetic and hospital surgical procedures.

When did APYX last file with the SEC?

Apyx Medical Corporation's most recent SEC filing on record is a DEF 14A filed 2026-06-26. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 07:28 UTC. This page is also available as JSON at /api/data?ticker=APYX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for APYX and 5,000+ tickers.

Create a free account — keep APYX
For your agent
GET /api/data?ticker=APYX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt